Saturday, February 1, 2025

Promising treatment for rectal cancer confirmed in major study

Compliance to preoperative chemotherapy in LARCT-US. Proportion of patients treated with chemotherapy per course. Four CAPOX cycles (or 6 FOLFOX) with at least 3 (5) cycles of oxaliplatin was provided to 208 (76%) patients and 239 (88%) patients received at least 75% of the number of prescribed chemotherapy cycles. Credit: eClinicalMedicine (2024). DOI: 10.1016/j.eclinm.2024.102771 A new treatment for locally advanced rectal cancer shows favorable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been confirmed as effective in a comprehensive study conducted at Uppsala University and published in eClinicalMedicine. “The Read More

No comments:

Post a Comment